Since our inception in 2004, our steadfast focus has been providing research grants to the worlds’ leading scientists researching Alzheimer’s disease. We are honored to work with scientists who are passionate in their pursuit to rid our world of this debilitating disease.

Many of the funded projects have resulted in significant breakthroughs in developing a better understanding of Alzheimer’s disease and getting closer to a cure.

Howard L. Weiner, Laura M. Cox, | 2022

Targeting the Microbiome and Innate Immunity in Alzheimer’s Disease

Ronald Schnaar, Tong Li, | 2022

Human Brain CD33 Ligand, Receptor Protein Tyrosine Phosphatase Zeta (RPTPζ)S3L, Limits Microglial Phagocytosis and Contributes to Alzheimer’s Disease Progression

Eng H. Lo, | 2022

Circadian Perturbations of the Vasculome and Microgliome in Alzheimer’s Disease

Takahisa Kanekiyo, | 2022

ABCA7 Loss of Function in Aging and Alzheimer’s Disease

Oskar Hansson, Rik Ossenkoppele, | 2022

Characterization of Tau Pathology Heterogeneity Across the Alzheimer’s Disease Spectrum

Se Hoon Choi, Christiane Wrann, | 2021

Neuroprotective Effects of the Exercise Hormone Irisin in Alzheimer’s Disease

Scott Russo, Wolfram Poller, | 2022

Stress and Neurovascular-Immune Networks in Alzheimer’s Disease

Bradley Hyman, John Dickson, | 2022

Properties of Tau in Posterior Cortical Atrophy

Helene Benveniste, Allen Tannenbaum, | 2022

Brain Entry and Exit Consortium: Central Nervous System Fluid Homeostasis and Waste Clearance in Alzheimer’s Disease Characterized by MRI

Richard Daneman, | 2022

Brain Entry and Exit Consortium: Identifying the Blood-Brain Barrier Changes During Alzheimer’s Disease

Helene Benveniste, Allen Tannenbaum, | 2022

Brain Entry and Exit Consortium: Central Nervous System Fluid Homeostasis and Waste Clearance in Alzheimer’s Disease Characterized by MRI

Robert Vassar, David Gate, Leah Cuddy, | 2022

Single Nucleus RNA Sequencing Analysis of ACE1 R1284Q Knock-in Mice

Funded Projects

The science that has advanced our understanding of Alzheimer's disease

Targeting the Microbiome and Innate Immunity in Alzheimer’s Disease

Human Brain CD33 Ligand, Receptor Protein Tyrosine Phosphatase Zeta (RPTPζ)S3L, Limits Microglial Phagocytosis and Contributes to Alzheimer’s Disease Progression

Circadian Perturbations of the Vasculome and Microgliome in Alzheimer’s Disease

ABCA7 Loss of Function in Aging and Alzheimer’s Disease

Characterization of Tau Pathology Heterogeneity Across the Alzheimer’s Disease Spectrum

Neuroprotective Effects of the Exercise Hormone Irisin in Alzheimer’s Disease

Stress and Neurovascular-Immune Networks in Alzheimer’s Disease

Properties of Tau in Posterior Cortical Atrophy

Brain Entry and Exit Consortium: Central Nervous System Fluid Homeostasis and Waste Clearance in Alzheimer’s Disease Characterized by MRI

Brain Entry and Exit Consortium: Identifying the Blood-Brain Barrier Changes During Alzheimer’s Disease

Brain Entry and Exit Consortium: Central Nervous System Fluid Homeostasis and Waste Clearance in Alzheimer’s Disease Characterized by MRI

Single Nucleus RNA Sequencing Analysis of ACE1 R1284Q Knock-in Mice